$XGN
EXAGEN INC. Stock $xgn

$xgn Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000127473721000044 Filed on May 11, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$10.59M	$9.584M
YoY Change	10.47%	3.5%
Cost Of Revenue	$4.711M	$4.545M
YoY Change	3.65%	2.32%
Gross Profit	$5.876M	$5.039M
YoY Change	16.61%	4.59%
Gross Profit Margin	55.5%	52.58%
Selling, General & Admin	$10.04M	$9.626M
YoY Change	4.3%	55.79%
% of Gross Profit	170.86%	191.03%
Research & Development	$1.403M	$634.0K
YoY Change	121.29%	23.59%
% of Gross Profit	23.88%	12.58%
Depreciation & Amortization	$200.0K	$100.0K
YoY Change	100.0%	-50.0%
% of Gross Profit	3.4%	1.98%
Operating Expenses	$11.44M	$10.26M
YoY Change	11.53%	53.32%
Operating Profit	-$5.567M	-$5.221M
YoY Change	6.63%	178.6%
Interest Expense	$645.0K	$631.0K
YoY Change	2.22%	-29.97%
% of Operating Profit
Other Income/Expense, Net	$3.000K	$171.0K
YoY Change	-98.25%	140.85%
Pretax Income	-$6.210M	-$5.680M
YoY Change	9.33%	110.37%
Income Tax	$0.00	-$118.0K
% Of Pretax Income
Net Earnings	-$6.209M	-$5.563M
YoY Change	11.61%	105.73%
Net Earnings / Revenue	-58.65%	-58.04%
Basic Earnings Per Share	-$0.48
Diluted Earnings Per Share	-$0.48	-$441.3K
COMMON SHARES
Basic Shares Outstanding	12.94M shares	12.63M shares
Diluted Shares Outstanding	12.94M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$118.1M	$68.60M
YoY Change	72.16%
Cash & Equivalents	$118.1M	$68.65M
Short-Term Investments
Other Short-Term Assets	$921.0K	$1.299M
YoY Change	-29.1%
Inventory
Prepaid Expenses
Receivables	$8.221M	$5.843M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$129.4M	$77.58M
YoY Change	66.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.378M	$1.376M
YoY Change	72.82%
Goodwill	$5.506M	$5.506M
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$269.0K	$187.0K
YoY Change	43.85%
Total Long-Term Assets	$8.153M	$7.069M
YoY Change	15.33%
TOTAL ASSETS
Total Short-Term Assets	$129.4M	$77.58M
Total Long-Term Assets	$8.153M	$7.069M
Total Assets	$137.5M	$84.64M
YoY Change	62.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.170M	$2.566M
YoY Change	-15.43%
Accrued Expenses	$5.714M	$4.763M
YoY Change	19.97%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$200.0K
YoY Change	100.0%
Total Short-Term Liabilities	$7.884M	$7.329M
YoY Change	7.57%
LONG-TERM LIABILITIES
Long-Term Debt	$26.86M	$26.05M
YoY Change	3.12%
Other Long-Term Liabilities	$1.146M	$581.0K
YoY Change	97.25%
Total Long-Term Liabilities	$28.01M	$26.63M
YoY Change	5.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.884M	$7.329M
Total Long-Term Liabilities	$28.01M	$26.63M
Total Liabilities	$36.05M	$34.11M
YoY Change	5.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$187.5M	-$170.2M
YoY Change	10.16%
Common Stock	$17.00K	$13.00K
YoY Change	30.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$101.5M	$50.54M
YoY Change
Total Liabilities & Shareholders Equity	$137.5M	$84.64M
YoY Change	62.47%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$6.209M	-$5.563M
YoY Change	11.61%	105.73%
Depreciation, Depletion And Amortization	$200.0K	$100.0K
YoY Change	100.0%	-50.0%
Cash From Operating Activities	-$4.312M	-$3.301M
YoY Change	30.63%	69.28%
INVESTING ACTIVITIES
Capital Expenditures	$167.0K	$84.00K
YoY Change	98.81%	-76.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$167.0K	-$84.00K
YoY Change	98.81%	-76.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$69.14M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$65.08M	-$51.00K
YoY Change	-127709.8%	-101.47%
NET CHANGE
Cash From Operating Activities	-$4.312M	-$3.301M
Cash From Investing Activities	-$167.0K	-$84.00K
Cash From Financing Activities	$65.08M	-$51.00K
Net Change In Cash	$60.60M	-$3.436M
YoY Change	-1863.74%	-395.44%
FREE CASH FLOW
Cash From Operating Activities	-$4.312M	-$3.301M
Capital Expenditures	$167.0K	$84.00K
Free Cash Flow	-$4.479M	-$3.385M
YoY Change	32.32%	46.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001274737
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	001-39049
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	EXAGEN INC.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-0434866
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1261 Liberty Way
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Vista,
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92081
CY2021Q1	dei	City Area Code CityAreaCode	(760)
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	560-1501
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	XGN
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16928278	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118050000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57448000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8221000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8910000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3098000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4159000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	129369000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	70517000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2378000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2102000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	5506000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	5506000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	269000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	250000	USD
CY2021Q1	us-gaap	Assets Assets	137522000	USD
CY2020Q4	us-gaap	Assets Assets	78375000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2170000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3014000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5714000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5757000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7884000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8771000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26864000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	26659000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	158000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	158000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1146000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	948000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	36052000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	36536000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16925680	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16925680	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12652308	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12652308	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	17000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	288951000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223115000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-187498000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-181289000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	101470000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41839000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	137522000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78375000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10587000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9584000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4711000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4545000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10040000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9626000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1403000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	634000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	16154000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	14805000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5567000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5221000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	645000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	631000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	171000	USD
CY2021Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-6209000	USD
CY2020Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5681000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-118000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6209000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-5563000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.48
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12943237	shares
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	12595715	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	41839000	USD
CY2021Q1	exdx	Stock Issuance Costs StockIssuanceCosts	4435000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	64709000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	44000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	175000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	912000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6209000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	101470000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55659000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	431000	USD
CY2020Q1	exdx	Stock Issued During Period Value Warrants Exercised Net StockIssuedDuringPeriodValueWarrantsExercisedNet	0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-5563000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	50537000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6209000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-5563000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	187000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	126000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	73000	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	65000	USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	132000	USD
CY2020Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	131000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-117000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	912000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	431000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-689000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	128000	USD
CY2021Q1	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-1061000	USD
CY2020Q1	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-367000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	48000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	14000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-792000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1054000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-317000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	347000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4312000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3301000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	167000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-167000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-84000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	44000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	175000	USD
CY2020Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	USD
CY2021Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	96000	USD
CY2020Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	61000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	69144000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4186000	USD
CY2020Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65081000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-51000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	60602000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3436000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57548000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72184000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118150000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68748000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	439000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	432000	USD
CY2021Q1	exdx	Equipment Purchased Under Capital Lease EquipmentPurchasedUnderCapitalLease	384000	USD
CY2020Q1	exdx	Equipment Purchased Under Capital Lease EquipmentPurchasedUnderCapitalLease	2000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	44000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37000	USD
CY2021Q1	exdx	Deferred Offering Costs Included Within Current Liabilities DeferredOfferingCostsIncludedWithinCurrentLiabilities	221000	USD
CY2020Q1	exdx	Deferred Offering Costs Included Within Current Liabilities DeferredOfferingCostsIncludedWithinCurrentLiabilities	0	USD
CY2021Q1	exdx	Deferred Offering Costs Reclassified To Equity DeferredOfferingCostsReclassifiedToEquity	28000	USD
CY2020Q1	exdx	Deferred Offering Costs Reclassified To Equity DeferredOfferingCostsReclassifiedToEquity	0	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118100000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-187500000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits.</span></div>
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10587000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9584000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118050000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57448000	USD
CY2021Q1	us-gaap	Restricted Cash RestrictedCash	100000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	100000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118150000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57548000	USD
CY2020Q4	exdx	Joint Venture Quarterly Promotion Fee Capped Amount Percentage Above Baseline JointVentureQuarterlyPromotionFeeCappedAmountPercentageAboveBaseline	0.05
CY2020Q3	exdx	Joint Venture Quarterly Promotion Fee Capped Amount Percentage Above Baseline JointVentureQuarterlyPromotionFeeCappedAmountPercentageAboveBaseline	0.05
CY2021Q1	exdx	Joint Venture Quarterly Prescribed Units JointVentureQuarterlyPrescribedUnits	28750	unit
CY2021Q1	exdx	Joint Venture Quarterly Promotion Fee Capped Amount Percentage Above Baseline JointVentureQuarterlyPromotionFeeCappedAmountPercentageAboveBaseline	0.10
CY2021Q1	exdx	Co Promotion Agreement Renewal Term CoPromotionAgreementRenewalTerm	P12M
CY2021Q1	exdx	Co Promotion Agreement Period Before Current Expiration To Extend Term CoPromotionAgreementPeriodBeforeCurrentExpirationToExtendTerm	P180D
CY2021Q1	exdx	Co Promotion Agreement Number Of Days Notice To Terminate Agreement CoPromotionAgreementNumberOfDaysNoticeToTerminateAgreement	P30D
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	300000	USD
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	400000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Prepaid Royalties PrepaidRoyalties	65000	USD
CY2021Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	200000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	100000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	921000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1203000	USD
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2656276	shares
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2068616	shares
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q1	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	4100000	USD
CY2020Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	68000	USD
CY2021Q1	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	1892000	USD
CY2020Q4	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	2229000	USD
CY2021Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	220000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	659000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3098000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4159000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5506000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5043000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3128000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2941000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2378000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2102000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	200000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	USD
CY2021Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	6000000.0	USD
CY2021Q1	exdx	Purchase Obligation Annual Increase In Commitment Percentage PurchaseObligationAnnualIncreaseInCommitmentPercentage	0.15
CY2021Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3318000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3589000	USD
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	148000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	147000	USD
CY2021Q1	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	493000	USD
CY2020Q4	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	311000	USD
CY2021Q1	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	188000	USD
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	221000	USD
CY2021Q1	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	286000	USD
CY2020Q4	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	228000	USD
CY2021Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	394000	USD
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	308000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	887000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	953000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5714000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5757000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1326000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2996000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	15619000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14280000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q1	exdx	Long Term Debt Including Undiscounted Interest LongTermDebtIncludingUndiscountedInterest	34221000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	273000	USD
CY2021Q1	exdx	Long Term Debt Undiscounted Interest Amount LongTermDebtUndiscountedInterestAmount	7084000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	26864000	USD
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	426827	shares
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	912000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	431000	USD
CY2020Q1	exdx	Coronavirus Aid Relief And Economic Securities Cares Act Deferred Tax Assets Valuation Allowance CoronavirusAidReliefAndEconomicSecuritiesCARESActDeferredTaxAssetsValuationAllowance	100000	USD
CY2020Q1	exdx	Coronavirus Aid Relief And Economic Securities Cares Act Deferred Tax Assets Income Tax Benefit CoronavirusAidReliefAndEconomicSecuritiesCARESActDeferredTaxAssetsIncomeTaxBenefit	100000	USD

Files In Submission

Name	View Source	Status
0001274737-21-000044-index-headers.html	Edgar Link	pending
0001274737-21-000044-index.html	Edgar Link	pending
0001274737-21-000044.txt	Edgar Link	pending
0001274737-21-000044-xbrl.zip	Edgar Link	pending
exdx-20210331.htm	Edgar Link	pending
exdx-20210331.xsd	Edgar Link	pending
exdx-20210331_cal.xml	Edgar Link	unprocessable
exdx-20210331_def.xml	Edgar Link	unprocessable
exdx-20210331_htm.xml	Edgar Link	completed
exdx-20210331_lab.xml	Edgar Link	unprocessable
exdx-20210331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xgn311-33121.htm	Edgar Link	pending
xgn312-33121.htm	Edgar Link	pending
xgn321-33121.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XGN
EXAGEN INC. Stock $xgn

2021 Q1 Form 10-Q Financial Statement

#000127473721000044 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN EXAGEN INC. Stock $xgn

2021 Q1 Form 10-Q Financial Statement

#000127473721000044 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN
EXAGEN INC. Stock $xgn